Free tool
FAERS Monitor: Suflave
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215344 or its brand name (Suflave, Magnesium Sulfate, Polyethylene Glycol 3350, Potassium Chloride, Sodium Chloride, Sodium Sulfate). Reports on generic versions are filed under their own applications.
Reports
108
Serious
15
14% of reports
Hospitalization
4
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea29
- vomiting23
- abdominal distension12
- headache10
- dehydration8
- drug ineffective8
- pruritus8
- abdominal pain7
- dizziness7
- urticaria7
- abdominal pain upper5
- asthenia5
- chills5
- loss of consciousness5
- abdominal discomfort4
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2022 | 1 |
| 2024 | 39 |
| 2025 | 47 |
| 2026 | 21 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,051 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| abdominal distensionSignal | 12 | 22.4 | 13.1 | 225 |
| dehydrationSignal | 8 | 11.7 | 6.0 | 68 |
| vomitingSignal | 23 | 9.5 | 6.6 | 171 |
| chillsSignal | 5 | 8.3 | 3.5 | 25 |
| urticariaSignal | 7 | 8.1 | 4.0 | 37 |
| loss of consciousnessSignal | 5 | 7.6 | 3.2 | 23 |
| nauseaSignal | 29 | 7.1 | 5.2 | 153 |
| abdominal painSignal | 7 | 5.9 | 2.9 | 24 |
| abdominal pain upperSignal | 5 | 4.7 | 2.0 | 11 |
| abdominal discomfortSignal | 4 | 4.6 | 1.8 | 8 |
| pruritusSignal | 8 | 4.1 | 2.1 | 16 |
| headacheSignal | 10 | 3.1 | 1.7 | 13 |
| dizzinessSignal | 7 | 2.7 | 1.3 | 6 |
| asthenia | 5 | 2.6 | 1.1 | 3 |
| drug ineffective | 8 | 1.2 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.